Vaccines Biologics Regulations
OBJECTIVESThis course intends to give you an overview of the different aspects of pharmacovigilance for vaccines and biologics.
LEARNING OUTCOMESAt the end of the course, you will have a knowledge and understanding of the major differences to ensure pharmacovigilance for vaccines and biologics as compared to other pharmaceutical products.
|
|
AUTHORS
![]() |
Dr. Peggy Webster Head of Vaccine Clinical Safety and Pharmacovigilance |
![]() |
Nasop Experts Group ISoP's North American chapter |